SFJ Pharma Raises $45 Million

SFJ Pharmaceuticals Inc., a platform for bringing U.S. and European drugs to Japan, has raised $45 million in Series A funding, according to VentureWire. Abingworth Management and Clarus Ventures co-led the round, which was designed to help the company acquire its first products. www.sfj-pharma.com (website not currently active)

Related Posts

1 Comment

Leave a Reply

PEHUB Community

Join the 12493 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget

Groups